checkAd

     101  0 Kommentare Changes in the Board of Directors and the Corporate Executive Committee of Roche

    Jörg Duschmalé

    Basel, 9 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting on 17 March 2020.

    Change in the Board of Directors
    As already announced in July 2018, Dr Andreas Oeri (70) will retire from the Board of Directors after 25 years in office with the Annual General Meeting in 2020. Dr Jörg Duschmalé (35), representing the fifth generation of the company's founder's descendants, will stand for election as his successor.

    Roche Chairman Christoph Franz: "Andreas Oeri has made a major personal contribution to Roche's success as a long-standing representative of the Oeri and Hoffmann families on the Board of Directors and as Chairman of the Corporate Governance and Sustainability Committee. We owe him our heartfelt thanks for his commitment. I am delighted that Jörg Duschmalé will stand for election as his successor at the upcoming Annual General Meeting 2020. This follows the recent announcement by the shareholder pool of the Hoffmann and Oeri families that seven further representatives of the fifth generation will join the pool to represent the company’s long-term interests.”

    After 18 years of service on the Board, Professor Sir John Bell has also decided not to stand for re-election to the Board of Directors at the 2020 Annual General Meeting. The Board of Directors will propose Dr Patrick Frost (51), CEO of the Swiss Life Group, for election at the Annual General Meeting in 2020.

    Roche Chairman Christoph Franz: "Sir John Bell, with his great scientific expertise, was indispensable for Roche's further development over the past almost 20 years. On behalf of Roche's Board of Directors, I would like to thank him most sincerely and wish him all the best for the future. I am very pleased that we have been able to propose Patrick Frost, a successful Swiss leader, for election to the Board of Directors."

    The following persons are recommended for election to the Board of Directors:

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Roche Holding AG Inhaber-Genussscheine!
    Long
    203,14€
    Basispreis
    1,86
    Ask
    × 12,13
    Hebel
    Short
    236,05€
    Basispreis
    1,91
    Ask
    × 11,81
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Name Board member since
    Dr Christoph Franz (as Chairman) 2011
    André Hoffmann 1996
    Julie Brown 2016
    Paul Bulcke 2011
    Professor Dr Hans Clevers 2019
    Dr Jörg Duschmalé new
    Dr Patrick Frost new
    Anita Hauser 2017
    Professor Dr Richard P. Lifton 2015
    Bernard Poussot 2015
    Dr Severin Schwan 2013
    Dr Claudia Süssmuth Dyckerhoff 2016
    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Changes in the Board of Directors and the Corporate Executive Committee of Roche Jörg Duschmalé Basel, 9 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting on 17 March 2020. …

    Schreibe Deinen Kommentar

    Disclaimer